Hudson Bay Capital Management
ARCT icon

Hudson Bay Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Hudson Bay Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,600
Closed -$195K – 1187
2025
Q3 		$195K Sell
10,600
-144,400
-93% -$2.32M ﹤0.01% 1028
2025
Q2 		$2.02M Buy
155,000
+100
+0.1% +$1.18K 0.01% 796
2025
Q1 		$1.64M Buy
154,900
+90,900
+142% +$1.44M 0.01% 856
2024
Q4 		$1.09M Buy
64,000
+20,000
+45% +$377K ﹤0.01% 733
2024
Q3 		$1.02M Buy
+44,000
New +$941K ﹤0.01% 670

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return